PA HB 2749: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.
PA HB 2749 amends the Controlled Substance, Drug, Device and Cosmetic Act to further provide for drug overdose medication, potentially expanding access to overdose reversal drugs like naloxone.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on August 26, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies in Pennsylvania. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified; bill is in legislative process.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The bill modifies provisions related to drug overdose medication, likely affecting how pharmacies dispense or distribute overdose reversal agents.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies in Pennsylvania.
What you must do
Monitor the bill's progress and review current dispensing protocols for overdose medications to ensure compliance once enacted.
Deadline
Not specified; bill is in legislative process.
Source: https://www.palegis.us/legislation/bills
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
- International Drug Scheduling; Single Convention on Narcotic Drugs; Convention on Psychotropic Substances; Clobromazolam (Phenazolam); Cychlorphine (N-Propionitrile Chlorphine); Desalkylgidazepam (Bromonordiazepam); Ethylbromazolam; Etomethazene (5-Methyl Etodesnitazene); Spirochlorphine (R6980); Etomidate; Medetomidine; Request for Comments
- Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV
- Catina Allen, N.P.; Decision and Order
- US-CONGRESS BILLS-119hr10133ih: Fair Prescription Pricing Act of 2026